Zero-order release of buprenorphine from an osmotically modulated once-a-day oral dosage form

2012 ◽  
Vol 13 (4) ◽  
pp. S77
Author(s):  
G. Yeola ◽  
P. Vavia ◽  
N. Babul ◽  
H. Kao
Biomaterials ◽  
2008 ◽  
Vol 29 (35) ◽  
pp. 4691-4697 ◽  
Author(s):  
Mohammad Hamdan Alkhraisat ◽  
Claus Moseke ◽  
Luis Blanco ◽  
Jake E. Barralet ◽  
Enrique Lopez-Carbacos ◽  
...  

1978 ◽  
Vol 12 (12) ◽  
pp. 720-727
Author(s):  
T. Donald Rucker ◽  
Leonard Janis ◽  
Marialice Bennett

This pilot study describes and suggests quality of care considerations related to prescriptions ordered by podiatrists for ambulatory patients. During the four-month survey period, the average podiatrist initiated 120 prescription orders and utilized 26 different drug entities. The 44 practitioners employed 235 different preparations, headed by Lotrimin®, Mepergan Fortis® and erythromycin. Although refill orders were judged as conservative, questions are raised about the use of oral dosage form combination products, agents employed infrequently, and the desired therapeutic intention of some preparations.


2014 ◽  
Vol 31 (10) ◽  
pp. 2844-2856 ◽  
Author(s):  
Filis Kazazi-Hyseni ◽  
Mariana Landin ◽  
Audrey Lathuile ◽  
Gert J. Veldhuis ◽  
Sima Rahimian ◽  
...  

2017 ◽  
Vol 8 (2) ◽  
pp. 368-374 ◽  
Author(s):  
Puneet Tyagi ◽  
Mika Koskinen ◽  
Jari Mikkola ◽  
Lasse Leino ◽  
Alexander Schwarz

1977 ◽  
Vol 25 (8) ◽  
pp. 1974-1979 ◽  
Author(s):  
RYOHEI HORI ◽  
KATSUHIKO OKUMURA ◽  
KENICHI INUI ◽  
NOBUKUNI NAKAMURA ◽  
AKIMA MIYOSHI ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document